Works matching AU Won, Jong Chul


Results: 48
    1
    2

    Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
    By:
    • Hong, Jun Hwa;
    • Kim, Myung Jin;
    • Min, Kyung Wan;
    • Won, Jong Chul;
    • Kim, Tae Nyun;
    • Lee, Byung‐Wan;
    • Kang, Jun Goo;
    • Kim, Jae Hyeon;
    • Park, Jung Hwan;
    • Ku, Bon Jeong;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Shon, Ho Sang;
    • Lee, Woo Je;
    • Park, Joong‐Yeol
    Publication type:
    Article
    3
    4
    5

    A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2188, doi. 10.1111/dom.15526
    By:
    • Lim, Soo;
    • Lee, Seung‐Hwan;
    • Min, Kyung‐Wan;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Yoo, Hye Jin;
    • Kim, Nan Hee;
    • Kim, Jae Hyeon;
    • Oh, Seungjoon;
    • Won, Jong Chul;
    • Kwon, Hyuk Sang;
    • Kim, Mi Kyung;
    • Park, Jung Hwan;
    • Jeong, In‐Kyung;
    • Kim, Sungrae
    Publication type:
    Article
    6

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 808, doi. 10.4093/dmj.2022.0387
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Hae Jin Kim;
    • Choon Hee Chung;
    • Kyu Chang Won;
    • Kyung Ah Han;
    • Cheol-Young Park;
    • Jong Chul Won;
    • Dong Jun Kim;
    • Gwan Pyo Koh;
    • Eun Sook Kim;
    • Jae Myung Yu;
    • Eun-Gyoung Hong;
    • Chang Beom Lee;
    • Kun-Ho Yoon
    Publication type:
    Article
    14
    15
    16

    The History of Insulin Therapy in Korea.

    Published in:
    Diabetes & Metabolism Journal, 2021, v. 45, n. 5, p. 623, doi. 10.4093/dmj.2021.0171
    By:
    • Jun Sung Moon;
    • Jong Chul Won;
    • Young Min Cho
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48